Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 7/20 | 0.50 |
| ▸ | PGGT1B | P53609 | 4/20 | 0.50 |
| ▸ | FNTB | P49356 | 4/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7626393 | 1.00 | FNTA (0.50) | FNTAPGGT1BFNTB | |
| SCHEMBL9417665 | 0.89 | FNTA (0.58) | FNTAPGGT1BFNTB | |
| SCHEMBL9417669 | 0.89 | FNTA (0.58) | FNTAPGGT1BFNTB | |
| SCHEMBL8461627 | 0.78 | FNTA (0.66) | FNTAPGGT1BFNTB | |
| SCHEMBL8460925 | 0.78 | FNTA (0.66) | FNTAPGGT1BFNTB | |
| SCHEMBL8459447 | 0.77 | FNTA (0.55) | FNTAPGGT1BFNTB | |
| SCHEMBL16079906 | 0.77 | FNTA (0.55) | FNTAPGGT1BFNTB | |
| SCHEMBL8459450 | 0.77 | FNTA (0.55) | FNTAPGGT1BFNTB | |
| SCHEMBL16079887 | 0.75 | FNTA (0.56) | FNTAPGGT1BFNTB | |
| SCHEMBL16079877 | 0.75 | FNTA (0.56) | FNTAPGGT1BFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20020006967-A1 | METHODS OF TREATMENT OF OCULAR NEOVASCULARIZATION | CAMPOCHIARO PETER A (US) | 2002-01-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020006967-A1 | METHODS OF TREATMENT OF OCULAR NEOVASCULARIZATION | GGT1, FNTA, PIGO | FNTA 2/4885PGGT1B 407/4885FNTB 11/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.